If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Katsuhisa Masaki is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Neuromyelitis Optica Medicine & Life Sciences
Multiple Sclerosis Medicine & Life Sciences
Aquaporin 4 Medicine & Life Sciences
Connexins Medicine & Life Sciences
Antibodies Medicine & Life Sciences
Connexin 43 Medicine & Life Sciences
Gap Junctions Medicine & Life Sciences
Myelitis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 650 Citations
  • 15 h-Index
  • 54 Article
  • 4 Comment/debate
  • 3 Letter
1 Citation (Scopus)

A novel model for treatment of hypertrophic pachymeningitis

Cui, Y., Masaki, K., Zhang, X., Yamasaki, R., Fujii, T., Ogata, H., Hayashida, S., Yamaguchi, H., Hyodo, F., Eto, H., Koyama, S., Iinuma, K., Yonekawa, T., Matsushita, T., Yoshida, M., Yamada, K., Kawano, M., Malissen, M., Malissen, B. & Kira, J-I., Mar 1 2019, In : Annals of Clinical and Translational Neurology. 6, 3, p. 431-444 14 p.

Research output: Contribution to journalArticle

Open Access
Transforming Growth Factors
Meningitis
irbesartan
Immunoglobulin G
B-Lymphocytes

Cerebrospinal fluid cytokine/chemokine/growth factor profiles in idiopathic hypertrophic pachymeningitis

Zhang, X., Fujii, T., Ogata, H., Yamasaki, R., Masaki, K., Cui, Y., Matsushita, T., Isobe, N. & Kira, J-I., May 15 2019, In : Journal of Neuroimmunology. 330, p. 38-43 6 p.

Research output: Contribution to journalArticle

Nervous System Diseases
Meningitis
Chemokines
Cerebrospinal Fluid
Intercellular Signaling Peptides and Proteins
Open Access
Myasthenia Gravis
Internet
Fatigue
Quality of Life
Research

Eculizumab improves fatigue in refractory generalized myasthenia gravis

The REGAIN Study Group, Aug 15 2019, In : Quality of Life Research. 28, 8, p. 2247-2254 8 p.

Research output: Contribution to journalArticle

Open Access
Myasthenia Gravis
Fatigue
Activities of Daily Living
Placebos
eculizumab
3 Citations (Scopus)

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

for the Regain Study Group, Jul 1 2019, In : Muscle and Nerve. 60, 1, p. 14-24 11 p.

Research output: Contribution to journalArticle

Open Access
Myasthenia Gravis
Safety
Meningococcal Infections
Muscle Strength
Activities of Daily Living